Joanne Edwards

University of Glasgow

Professor Joanne Edwards obtained a BSc in Pharmacology from the University of Glasgow followed by her PhD in Cancer Biology from the University of St Andrews. She became a Fellow of the Royal College of Pathologists in 2012 (published works). Her scientific career has included working as a Clinical Scientist in Glasgow Royal Infirmary, followed by a Senior Lecture in the Institute of Cancer Sciences University of Glasgow and more recently in January this year became a Professor of Translational Cancer Pathology. Her research portfolio focuses on investigation of signal transduction mechanisms associated with the development and progression of breast, colorectal and prostate cancer. Her aim is to identify clinically relevant aberrations in the human solid tumours and establish if they can be employed in clinical practise to improve patient care and outcome.

dont miss

Role of IKK alpha in Breast Cancer

Triple negative breast cancer (TNBC) is the most aggressive subtype of breast carcinoma with limited therapeutic options. IKKα, the main catalytic kinase in the NF-κB non-canonical pathway, may be a novel therapeutic target for treatment of TNBC as elevated levels of phosphorylated IKKα in TNBC specimens is associated with reduced cancer specific survival and treatment of TNBC cell lines with IKKα inhibitors results in reduced cell viability.

Joanne Edwards will be speaking in the following theatre:

Theatre 11 - Tuesday 12.30 - 13.00: Role of IKK alpha in Breast Cancer

EVEN MORE SEMINARS

  • Jocelyn Harding CEB DipDH: Speaking at the Oncology Convention

    Jocelyn Harding CEB DipDH
    Oralieve UK

    The importance of mouth care for cancer patients

  • Sally Hayes: Speaking at the Oncology Convention

    Sally Hayes
    Maggie’s

    Maggie’s programme of emotional support

  • Professor Farzin Farzaneh: Speaking at the Oncology Convention

    Professor Farzin Farzaneh
    King’s College London

    Advanced Therapy Medicinal Products (ATMPs) for achievement of deeper and longer lasting immune mediated cancer remission

  • Dr. Omar Milhem: Speaking at the Oncology Convention

    Dr. Omar Milhem
    Pharma Medico Ltd

    Clinical Management of Proteoglycan Follicular Atrophy in Female Hair Loss

  • Dr. Matthew Prime: Speaking at the Oncology Convention

    Dr. Matthew Prime
    Roche Diagnostics Information Solutions

    Personalized healthcare: Leveraging data to improve patient care through clinical decision support in oncology